{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:50:30Z","timestamp":1789426230396,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00259-023-06537-1","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T20:02:06Z","timestamp":1701892926000},"page":"1349-1360","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Performance of [18F]fluorocholine PET\/CT in MEN1-related primary hyperparathyroidism before initial surgery or for persistent\/recurrent disease"],"prefix":"10.1007","volume":"51","author":[{"given":"Aymeric","family":"Boucher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Delabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lussey-Lepoutre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Haissaguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ouvrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vija","family":"Lavinia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eblle","family":"Le Bras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Batisse-Lignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Jacquet-Francillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Gaujoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oc\u00e9ane","family":"Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Latge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Ansquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghoufrane","family":"Tlili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Hamidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Romanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-7600","authenticated-orcid":false,"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"key":"6537_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17)31430-7","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet. 2018;391:168\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(17)31430-7.","journal-title":"Lancet"},{"key":"6537_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/s41574-021-00468-3","volume":"17","author":"A Al-Salameh","year":"2021","unstructured":"Al-Salameh A, Cadiot G, Calender A, Goudet P, Chanson P. Clinical aspects of multiple endocrine neoplasia type 1. Nat Rev Endocrinol. 2021;17:207\u201324. https:\/\/doi.org\/10.1038\/s41574-021-00468-3.","journal-title":"Nat Rev Endocrinol"},{"key":"6537_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","volume":"272","author":"S Vinault","year":"2020","unstructured":"Vinault S, Mariet AS, Le Bras M, Mirallie E, Cardot-Bauters C, Pattou F, et al. Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: a GTE and AFCE cohort study (Groupe d\u2019etude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne). Ann Surg. 2020;272:1094\u2013101. https:\/\/doi.org\/10.1097\/SLA.0000000000003162.","journal-title":"Ann Surg"},{"key":"6537_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MD.0b013e3182954af1","volume":"92","author":"T Ito","year":"2013","unstructured":"Ito T, Igarashi H, Uehara H, Berna MJ, Jensen RT. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1\/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore). 2013;92:135\u201381. https:\/\/doi.org\/10.1097\/MD.0b013e3182954af1.","journal-title":"Medicine (Baltimore)"},{"key":"6537_CR5","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1097\/SLA.0000000000001211","volume":"261","author":"JA Norton","year":"2015","unstructured":"Norton JA, Krampitz G, Zemek A, Longacre T, Jensen RT. Better survival but changing causes of death in patients with multiple endocrine neoplasia type 1. Ann Surg. 2015;261:e147\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000001211.","journal-title":"Ann Surg"},{"key":"6537_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","volume":"34","author":"P Goudet","year":"2010","unstructured":"Goudet P, Murat A, Binquet C, Cardot-Bauters C, Costa A, Ruszniewski P, et al. Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg. 2010;34:249\u201355. https:\/\/doi.org\/10.1007\/s00268-009-0290-1.","journal-title":"World J Surg."},{"key":"6537_CR7","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1210\/jc.2002-021314","volume":"88","author":"F Gibril","year":"2003","unstructured":"Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, et al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2003;88:1066\u201381. https:\/\/doi.org\/10.1210\/jc.2002-021314.","journal-title":"J Clin Endocrinol Metab"},{"key":"6537_CR8","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/bjs\/znac006","volume":"109","author":"S Gaujoux","year":"2022","unstructured":"Gaujoux S, Martin GL, Mirallie E, Regenet N, Le Bras M, Pattou F, et al. Life expectancy and likelihood of surgery in multiple endocrine neoplasia type 1: AFCE and GTE cohort study. Br J Surg. 2022;109:872\u20139. https:\/\/doi.org\/10.1093\/bjs\/znac006.","journal-title":"Br J Surg"},{"key":"6537_CR9","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012;97:2990\u20133011. https:\/\/doi.org\/10.1210\/jc.2012-1230.","journal-title":"J Clin Endocrinol Metab"},{"key":"6537_CR10","doi-asserted-by":"publisher","unstructured":"Santucci N, Ksiazek E, Pattou F, Baud G, Mirallie E, Frey S, et al. Recurrence after surgery for primary hyperparathyroidism in 517 patients with multiple endocrine neoplasia type 1. An AFCE and GTE study (Association Francophone de Chirurgie Endocrinienne and Groupe d'etude des Tumeurs Endocrines). Ann Surg. 2023. https:\/\/doi.org\/10.1097\/SLA.0000000000005980.","DOI":"10.1097\/SLA.0000000000005980"},{"key":"6537_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","volume":"23","author":"N Nilubol","year":"2016","unstructured":"Nilubol N, Weinstein LS, Simonds WF, Jensen RT, Marx SJ, Kebebew E. Limited parathyroidectomy in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism: a setup for failure. Ann Surg Oncol. 2016;23:416\u201323. https:\/\/doi.org\/10.1245\/s10434-015-4865-9.","journal-title":"Ann Surg Oncol"},{"key":"6537_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.surg.2013.03.004","volume":"154","author":"M Versnick","year":"2013","unstructured":"Versnick M, Popadich A, Sidhu S, Sywak M, Robinson B, Delbridge L. Minimally invasive parathyroidectomy provides a conservative surgical option for multiple endocrine neoplasia type 1-primary hyperparathyroidism. Surgery. 2013;154:101\u20135. https:\/\/doi.org\/10.1016\/j.surg.2013.03.004.","journal-title":"Surgery"},{"key":"6537_CR13","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1038\/s41598-020-67424-5","volume":"10","author":"HR Choi","year":"2020","unstructured":"Choi HR, Choi SH, Choi SM, Kim JK, Lee CR, Kang SW, et al. Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism. Sci Rep. 2020;10:10634. https:\/\/doi.org\/10.1038\/s41598-020-67424-5.","journal-title":"Sci Rep"},{"key":"6537_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00259-018-4123-z","volume":"46","author":"G Treglia","year":"2019","unstructured":"Treglia G, Piccardo A, Imperiale A, Strobel K, Kaufmann PA, Prior JO, et al. Diagnostic performance of choline PET for detection of hyperfunctioning parathyroid glands in hyperparathyroidism: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2019;46:751\u201365. https:\/\/doi.org\/10.1007\/s00259-018-4123-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6537_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2967\/jnumed.119.229914","volume":"61","author":"A Cuderman","year":"2020","unstructured":"Cuderman A, Senica K, Rep S, Hocevar M, Kocjan T, Sever MJ, et al. (18)F-Fluorocholine PET\/CT in primary hyperparathyroidism: superior diagnostic performance to conventional scintigraphic imaging for localization of hyperfunctioning parathyroid glands. J Nucl Med. 2020;61:577\u201383. https:\/\/doi.org\/10.2967\/jnumed.119.229914.","journal-title":"J Nucl Med"},{"key":"6537_CR16","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00259-021-05334-y","volume":"48","author":"P Petranovic Ovcaricek","year":"2021","unstructured":"Petranovic Ovcaricek P, Giovanella L, Carrio Gasset I, Hindie E, Huellner MW, Luster M, et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging. 2021;48:2801\u201322. https:\/\/doi.org\/10.1007\/s00259-021-05334-y.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6537_CR17","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1007\/s00268-020-05695-9","volume":"44","author":"M Gauthe","year":"2020","unstructured":"Gauthe M, Dierick-Gallet A, Delbot T, Bricaire L, Bertherat J, North MO, et al. (18)F-fluorocholine PET\/CT in MEN1 patients with primary hyperparathyroidism. World J Surg. 2020;44:3761\u20139. https:\/\/doi.org\/10.1007\/s00268-020-05695-9.","journal-title":"World J Surg"},{"key":"6537_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.23736\/S1824-4785.22.03440-9","volume":"66","author":"JN Talbot","year":"2022","unstructured":"Talbot JN, Zhang-Yin J, Kerrou K, Aveline C, Vagne B, Belissant O, et al. Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET\/CT. Illustrative cases and pitfalls. Q J Nucl Med Mol Imaging. 2022;66:130\u201340. https:\/\/doi.org\/10.23736\/S1824-4785.22.03440-9.","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"6537_CR19","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1097\/MNM.0000000000000595","volume":"37","author":"WP Kluijfhout","year":"2016","unstructured":"Kluijfhout WP, Vorselaars WM, van den Berk SA, Vriens MR, Borel Rinkes IH, Valk GD, et al. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands. Nucl Med Commun. 2016;37:1246\u201352. https:\/\/doi.org\/10.1097\/MNM.0000000000000595.","journal-title":"Nucl Med Commun"},{"key":"6537_CR20","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1007\/s00330-017-5190-4","volume":"28","author":"GF Huber","year":"2018","unstructured":"Huber GF, Hullner M, Schmid C, Brunner A, Sah B, Vetter D, et al. Benefit of (18)F-fluorocholine PET imaging in parathyroid surgery. Eur Radiol. 2018;28:2700\u20137. https:\/\/doi.org\/10.1007\/s00330-017-5190-4.","journal-title":"Eur Radiol"},{"key":"6537_CR21","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1007\/s00259-018-4018-z","volume":"45","author":"S Grimaldi","year":"2018","unstructured":"Grimaldi S, Young J, Kamenicky P, Hartl D, Terroir M, Leboulleux S, et al. Challenging pre-surgical localization of hyperfunctioning parathyroid glands in primary hyperparathyroidism: the added value of (18)F-fluorocholine PET\/CT. Eur J Nucl Med Mol Imaging. 2018;45:1772\u201380. https:\/\/doi.org\/10.1007\/s00259-018-4018-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6537_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fendo.2017.00380","volume":"8","author":"S Fischli","year":"2017","unstructured":"Fischli S, Suter-Widmer I, Nguyen BT, Muller W, Metzger J, Strobel K, et al. The significance of 18F-fluorocholine-PET\/CT as localizing imaging technique in patients with primary hyperparathyroidism and negative conventional imaging. Front Endocrinol (Lausanne). 2017;8:380. https:\/\/doi.org\/10.3389\/fendo.2017.00380.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"6537_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13550-019-0544-3","volume":"9","author":"WAM Broos","year":"2019","unstructured":"Broos WAM, Wondergem M, Knol RJJ, van der Zant FM. Parathyroid imaging with (18)F-fluorocholine PET\/CT as a first-line imaging modality in primary hyperparathyroidism: a retrospective cohort study. EJNMMI Res. 2019;9:72. https:\/\/doi.org\/10.1186\/s13550-019-0544-3.","journal-title":"EJNMMI Res"},{"key":"6537_CR24","doi-asserted-by":"publisher","first-page":"3S","DOI":"10.2967\/jnumed.120.245993","volume":"62","author":"E Hindie","year":"2021","unstructured":"Hindie E, Schwartz P, Avram AM, Imperiale A, Sebag F, Taieb D. Primary hyperparathyroidism: defining the appropriate preoperative imaging algorithm. J Nucl Med. 2021;62:3S-12S. https:\/\/doi.org\/10.2967\/jnumed.120.245993.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-023-06537-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-023-06537-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T07:04:02Z","timestamp":1711004642000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-023-06537-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["6537"],"URL":"https:\/\/doi.org\/10.1007\/s00259-023-06537-1","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"11 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Assistance Publique-H\u00f4pitaux de Marseille ethics advisory committee (no. PADS23-064).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Waiver of explicit patient consent was granted by the ethics committee, given the retrospective nature of the study (MR004 compliance).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for the publication of the images in Fig.\u00a0\n                      \n                      A\u2013D.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AB, TC, CL, FS, ZH, PR, FBC, JD, OM, EO, AI, ML, VL, AL, SG, and GT declare they have no financial interests.DT, AK, NJF, MH, CA, and MBL have received speaker and consultant honoraria from AAA\/Novartis.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}